S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
S&P 500   2,954.22 (-0.82%)
DOW   25,409.36 (-1.39%)
QQQ   205.80 (+0.08%)
AAPL   273.36 (-0.06%)
FB   192.47 (+1.43%)
MSFT   162.01 (+2.42%)
GOOGL   1,339.25 (+1.85%)
AMZN   1,883.75 (-0.03%)
CGC   18.78 (+1.84%)
NVDA   270.07 (+6.92%)
BABA   208.00 (+1.45%)
MU   52.56 (+3.91%)
GE   10.88 (+4.72%)
TSLA   667.99 (-1.62%)
AMD   45.48 (+3.34%)
T   35.22 (-1.43%)
ACB   1.34 (-7.59%)
F   6.96 (-0.14%)
NFLX   369.03 (-0.72%)
PRI   111.34 (-3.00%)
BAC   28.50 (-2.16%)
GILD   69.36 (-4.54%)
DIS   117.65 (-0.33%)
Log in

NASDAQ:NXGN - Nextgen Healthcare Stock Price, Forecast & News

$13.08
+0.06 (+0.46 %)
(As of 02/28/2020 04:00 PM ET)
Today's Range
$12.72
Now: $13.08
$13.50
50-Day Range
$13.02
MA: $14.51
$16.24
52-Week Range
$12.71
Now: $13.08
$21.12
Volume383,181 shs
Average Volume219,590 shs
Market Capitalization$859.37 million
P/E Ratio54.50
Dividend YieldN/A
Beta1.1
NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based electronic health record and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile Health Solutions, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health and NextGen Share interoperability solutions. It also provides professional services, including training, project management, functional and detailed specification preparation, configuration, testing, installation, support, and client services. It serves physician hospital and management service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. NextGen Healthcare, Inc. has a strategic partnership with OTTO Health LLC. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was founded in 1974 and is headquartered in Irvine, California.

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NXGN
CUSIPN/A
CIKN/A
Phone949-255-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$529.17 million
Cash Flow$1.28 per share
Book Value$6.08 per share

Profitability

Net Income$24.49 million

Miscellaneous

Employees2,660
Market Cap$859.37 million
Next Earnings Date5/26/2020 (Estimated)
OptionableOptionable

Receive NXGN News and Ratings via Email

Sign-up to receive the latest news and ratings for NXGN and its competitors with MarketBeat's FREE daily newsletter.


Nextgen Healthcare (NASDAQ:NXGN) Frequently Asked Questions

What is Nextgen Healthcare's stock symbol?

Nextgen Healthcare trades on the NASDAQ under the ticker symbol "NXGN."

How were Nextgen Healthcare's earnings last quarter?

Nextgen Healthcare Inc (NASDAQ:NXGN) issued its quarterly earnings results on Thursday, January, 23rd. The company reported $0.23 EPS for the quarter, topping the Zacks' consensus estimate of $0.20 by $0.03. The company earned $137.70 million during the quarter, compared to analysts' expectations of $135.37 million. Nextgen Healthcare had a return on equity of 10.58% and a net margin of 2.91%. The firm's revenue was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.18 EPS. View Nextgen Healthcare's Earnings History.

When is Nextgen Healthcare's next earnings date?

Nextgen Healthcare is scheduled to release their next quarterly earnings announcement on Tuesday, May 26th 2020. View Earnings Estimates for Nextgen Healthcare.

What guidance has Nextgen Healthcare issued on next quarter's earnings?

Nextgen Healthcare updated its FY20 earnings guidance on Thursday, January, 23rd. The company provided earnings per share guidance of $0.80-$0.84 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.83. The company issued revenue guidance of $541-$547 million, compared to the consensus revenue estimate of $540.81 million.

What price target have analysts set for NXGN?

10 Wall Street analysts have issued twelve-month price objectives for Nextgen Healthcare's stock. Their forecasts range from $1.00 to $22.00. On average, they expect Nextgen Healthcare's share price to reach $14.13 in the next year. This suggests a possible upside of 8.0% from the stock's current price. View Analyst Price Targets for Nextgen Healthcare.

What is the consensus analysts' recommendation for Nextgen Healthcare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nextgen Healthcare in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nextgen Healthcare.

Has Nextgen Healthcare been receiving favorable news coverage?

News headlines about NXGN stock have been trending positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Nextgen Healthcare earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Nextgen Healthcare.

Are investors shorting Nextgen Healthcare?

Nextgen Healthcare saw a drop in short interest in January. As of January 31st, there was short interest totalling 1,570,000 shares, a drop of 20.7% from the January 15th total of 1,980,000 shares. Based on an average daily trading volume, of 315,800 shares, the short-interest ratio is presently 5.0 days. Approximately 3.2% of the company's shares are sold short. View Nextgen Healthcare's Current Options Chain.

Who are some of Nextgen Healthcare's key competitors?

What other stocks do shareholders of Nextgen Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nextgen Healthcare investors own include Altria Group (MO), Twitter (TWTR), Verizon Communications (VZ), Huntington Bancshares (HBAN), Enterprise Products Partners (EPD), Marathon Petroleum (MPC), Merck & Co., Inc. (MRK), Tapestry (TPR), Welltower (WELL) and Exxon Mobil (XOM).

Who are Nextgen Healthcare's key executives?

Nextgen Healthcare's management team includes the folowing people:
  • Mr. John R. Frantz, Pres, CEO & Director (Age 52)
  • Mr. James Robert Arnold Jr., Exec. VP, CFO & Principal Accounting Officer (Age 63)
  • Mr. David A. Metcalfe, Exec. VP & Chief Technology Officer (Age 56)
  • Mr. Jeffrey D. Linton, Exec. VP, Gen. Counsel & Sec. (Age 56)
  • Mr. Scott E. Bostick, Non-Exec. Officer (Age 54)

Who are Nextgen Healthcare's major shareholders?

Nextgen Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include State Street Corp (2.36%), New York State Common Retirement Fund (2.28%), Investment Counselors of Maryland LLC (2.07%), Geode Capital Management LLC (1.49%), AQR Capital Management LLC (0.87%) and Bank of New York Mellon Corp (0.86%). Company insiders that own Nextgen Healthcare stock include George H Bristol and Sheldon Razin. View Institutional Ownership Trends for Nextgen Healthcare.

Which institutional investors are selling Nextgen Healthcare stock?

NXGN stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace LLP, Thrivent Financial for Lutherans, First Trust Advisors LP, AQR Capital Management LLC, Oxford Asset Management LLP, Connor Clark & Lunn Investment Management Ltd., Geode Capital Management LLC and Charles Schwab Investment Management Inc.. Company insiders that have sold Nextgen Healthcare company stock in the last year include George H Bristol and Sheldon Razin. View Insider Buying and Selling for Nextgen Healthcare.

Which institutional investors are buying Nextgen Healthcare stock?

NXGN stock was bought by a variety of institutional investors in the last quarter, including Panagora Asset Management Inc., Prudential Financial Inc., California Public Employees Retirement System, Martingale Asset Management L P, Mackay Shields LLC, Bessemer Group Inc., Jacobs Levy Equity Management Inc. and State Street Corp. View Insider Buying and Selling for Nextgen Healthcare.

How do I buy shares of Nextgen Healthcare?

Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Nextgen Healthcare's stock price today?

One share of NXGN stock can currently be purchased for approximately $13.08.

How big of a company is Nextgen Healthcare?

Nextgen Healthcare has a market capitalization of $859.37 million and generates $529.17 million in revenue each year. The company earns $24.49 million in net income (profit) each year or $0.61 on an earnings per share basis. Nextgen Healthcare employs 2,660 workers across the globe.View Additional Information About Nextgen Healthcare.

What is Nextgen Healthcare's official website?

The official website for Nextgen Healthcare is http://www.nextgen.com/.

How can I contact Nextgen Healthcare?

Nextgen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at 949-255-2600 or via email at [email protected]


MarketBeat Community Rating for Nextgen Healthcare (NASDAQ NXGN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  104 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  241
MarketBeat's community ratings are surveys of what our community members think about Nextgen Healthcare and other stocks. Vote "Outperform" if you believe NXGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/28/2020 by MarketBeat.com Staff

Featured Article: Cost of Goods Sold (COGS)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel